IBDEI1NA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27522,0)
 ;;=R39.11^^132^1316^64
 ;;^UTILITY(U,$J,358.3,27522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27522,1,3,0)
 ;;=3^Micturition Hesitancy
 ;;^UTILITY(U,$J,358.3,27522,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,27522,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,27523,0)
 ;;=R39.16^^132^1316^95
 ;;^UTILITY(U,$J,358.3,27523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27523,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,27523,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,27523,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,27524,0)
 ;;=R36.0^^132^1316^97
 ;;^UTILITY(U,$J,358.3,27524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27524,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,27524,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,27524,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,27525,0)
 ;;=R36.9^^132^1316^98
 ;;^UTILITY(U,$J,358.3,27525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27525,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,27525,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,27525,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,27526,0)
 ;;=R97.2^^132^1316^27
 ;;^UTILITY(U,$J,358.3,27526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27526,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,27526,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,27526,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,27527,0)
 ;;=R80.1^^132^1316^87
 ;;^UTILITY(U,$J,358.3,27527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27527,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,27527,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,27527,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,27528,0)
 ;;=R80.0^^132^1316^85
 ;;^UTILITY(U,$J,358.3,27528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27528,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,27528,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,27528,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,27529,0)
 ;;=R80.8^^132^1316^88
 ;;^UTILITY(U,$J,358.3,27529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27529,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,27529,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,27529,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,27530,0)
 ;;=R80.3^^132^1316^84
 ;;^UTILITY(U,$J,358.3,27530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27530,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,27530,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,27530,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,27531,0)
 ;;=R80.9^^132^1316^89
 ;;^UTILITY(U,$J,358.3,27531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27531,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,27531,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,27531,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,27532,0)
 ;;=Z87.442^^132^1316^77
 ;;^UTILITY(U,$J,358.3,27532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27532,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,27532,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,27532,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,27533,0)
 ;;=N18.1^^132^1316^13
 ;;^UTILITY(U,$J,358.3,27533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27533,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,27533,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,27533,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,27534,0)
 ;;=N18.2^^132^1316^14
 ;;^UTILITY(U,$J,358.3,27534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27534,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,27534,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,27534,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,27535,0)
 ;;=N18.3^^132^1316^15
 ;;^UTILITY(U,$J,358.3,27535,1,0)
 ;;=^358.31IA^4^2
